Conference abstractPublished 23 Nov 2012
Preparation and characterization of self-emulsifying drug delivery system (SEDDS) of indomethacin
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Indomethacin, a poorly soluble and highly permeable non-steroidal anti-inflammatory drug, used to reduce pain, swelling involved in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Indomethacin shows low and erratic oral bioavailability due to poor solubility. The main purpose of this work was to develop self emulsifying drug delivery system (SEDDS) to enhance oral bioavailability of indomethacin. SEDDS is mixture of oils, surfactants, and co-surfactants, which are emulsified in aqueous media under conditions of gentle agitation and digestive motility that would be encountered in the gastro-intestinal (GI) tract. Solubility of indomethacin was determined in various vehicles. Pseudoternary phase diagrams were constructed to identify the efficient self-emulsifying region. Based on solubility and Isotropicity studies and emulsifying ability labrafil, cremophor EL and transcutol P were selected as oil, surfactant and co surfactant respectively. The developed SEDDS were evaluated for its percentage transmittance, assay, phase separation study, droplet size analysis, zeta potential, turbidity, viscosity and in vitro release studies. In vitro release studies were carried by using USP dissolution apparatus XXIV-Type II. Antiinflammatory studies were conducted in Wistar strain male albino rats by using optimized formulation, drug suspension and marketed product. Optimized formulation showed significant anti-inflammatory activity than the drug suspension and marketed product. Our studies illustrated that the developed SEDDS is potential alternative for the immediate delivery of hydrophobic compounds such as indomethacin by oral route.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Damineni Saritha”
